Protalix BioTherapeutics (PBDA.F) Q3 2024 Earnings

Aug 14Confirmed
Q2 2024
Q3 2024
-0.06
-0.03
-0.01
0.02

Details

Expected EPS
0.018160000000000003
Actual EPS
-0.02724
Surprise EPS
-0.05
Surprise Percent
-250%

Description

⁨Protalix BioTherapeutics⁩ (⁦PBDA.F⁩) has reported earnings of ⁦-0.02724⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts